反感性寡核酸治疗降低IL-1β表达并延长突变NLRP3小鼠的生存期
Benedikt Kaufmann1,2, Marta de Los Reyes Jiménez3, Laela M Booshehri1
1Department of Pediatrics, University of California San Diego, La Jolla, CA.
Journal of immunology (Baltimore, Md. : 1950)
|May 31, 2023
概括
针对NLRP3基因的反感性寡核酸 (ASO) 能够有效地降低酸相关周期性综合征 (CAPS) 模型中的炎症. 这项研究表明,ASO疗法是对CAPS和其他NLRP3介导的炎症性疾病的有希望的治疗方法.
科学领域:
- 遗传学和分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低氨酸相关周期性综合征 (CAPS) 是由NLRP3功能获取突变驱动的自身炎症性疾病.
- 通过NLRP3炎症酶激活,通过IL-1β释放导致全身和组织炎症.
- 反感性寡核酸 (ASO) 提供了向基因沉默治疗方法.
研究的目的:
- 评估一种Nlrp3特异性抗感性寡核酸 (ASO) 在治疗冷氨酸相关周期性综合征 (CAPS) 的疗效.
- 在临床前CAPS模型中评估NLRP3特异性ASO对NLRP3表达和IL-1β产生的影响.
主要方法:
- 在小鼠细胞系和骨髓衍生巨细胞 (BMDMs) 中设计和测试了一种Nlrp3特异性的ASO.
- 将Nlrp3特异性ASO给Nlrp3试验小鼠,并监测存活率,Nlrp3和IL-1β表达.
- 从Nlrp3突变BMDMs中评估IL-1β释放,这些BMDMs被用Nlrp3特异性ASO治疗.
主要成果:
- 特定于Nlrp3的ASO显著降低了Nlrp3和细胞系和BMDM中的成熟IL-1β表达.
- 活体治疗减少了Nlrp3突变BMDMs中的IL-1β释放.
- 在体内治疗延长了Nlrp3突变小鼠的生存时间,减少了全身炎症,降低了组织Nlrp3和IL-1β水平.
结论:
- 在CAPS模型中,NLRP3特定的ASO治疗有效抑制NLRP3表达和IL-1β释放.
- ASO疗法为CAPS和其他由NLRP3炎症酶激活驱动的疾病提供了潜在的治疗策略.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K


